Guest post: Catriona Hammer on the CIPA Congress

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Guest post: Catriona Hammer on the CIPA Congress

The CIPA President outlines the agenda for this week’s annual Congress

We are very excited about our annual Congress this week and are delighted that our IP Minister, Baroness Neville-Rolfe, will be attending to give the opening keynote address. Her business background should give her plenty to say on the topic of IP.

She has already led a highly successful delegation to China in which CIPA was pleased to be represented by Gwilym Roberts.

The Congress theme is “The Lifecycle of Intellectual Property: Intellectual property from cradle to grave”. We look forward to hearing from a full programme of distinguished speakers taking us all the way through from recognising inventions to licensing and litigation.



There will be a keynote speech from Heli Pihlajamaa of the EPO after lunch on the opening day.

In addition, we expect a provocative lunchtime debate on the second day when Dr Mohga Kamal-Yanni, Senior Health and HIV Policy Advisor for Oxfam GB, will speak on the effect that the charity believes “Big Pharma” companies are having on public health in the developing world and John Pender from Glaxo Smithkline will reply for the industry.

For those attending the President’s Dinner, there will be the Rt Hon The Lord Justice Vos as guest speaker – plus a few surprises in store.

There is certainly a lot happening in the world of IP and CIPA is actively engaged in a diverse range of issues such as: the European Trade Mark Directive and Regulations; the proposed Trade Secrets Directive and, of course, the ongoing saga of the Unitary Patent and Unified Patent Court. All of these topics feature on the agenda for Congress and, of course, we expect to get many contributions and questions from the audience.

more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article